An animal study to compare the degree of the suppressive effects on the afferent pathways of micturition between tamsulosin and sildenafil

[1]  K. Kim,et al.  Effects of Tamsulosin on Urinary Bladder Function and Neuronal Activity in the Voiding Centers of Rats with Cyclophosphamide-induced Overactive Bladder , 2012, International neurourology journal.

[2]  K. Ishibashi,et al.  Long‐term administration of prazosin improves bladder storage function: Results from a study in spontaneously hypertensive rats , 2011, International journal of urology : official journal of the Japanese Urological Association.

[3]  C. Cruz,et al.  Nerve growth factor in bladder dysfunction: Contributing factor, biomarker, and therapeutic target , 2011, Neurourology and urodynamics.

[4]  M. Oelke,et al.  Phosphodiesterase (PDE) inhibitors in the treatment of lower urinary tract dysfunction. , 2011, British journal of clinical pharmacology.

[5]  K. Kim,et al.  Swimming: Effects on Stress Urinary Incontinence and the Expression of Nerve Growth Factor in Rats Following Transabdominal Urethrolysis , 2011, International neurourology journal.

[6]  C. Roehrborn,et al.  The effects of dutasteride or tamsulosin alone and in combination on storage and voiding symptoms in men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH): 4‐year data from the Combination of Avodart and Tamsulosin (CombAT) study , 2011, BJU international.

[7]  D. Behr-Roussel,et al.  Nitric oxide/cyclic guanosine monophosphate signalling mediates an inhibitory action on sensory pathways of the micturition reflex in the rat. , 2010, European urology.

[8]  M. Chancellor,et al.  Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence , 2010, Neurourology and urodynamics.

[9]  Naoki Yoshimura,et al.  Changes in afferent activity after spinal cord injury , 2010, Neurourology and urodynamics.

[10]  O. Yokoyama.  Pharmacological and genetic analysis of mechanisms underlying detrusor overactivity in rats , 2010, Neurourology and urodynamics.

[11]  K. Andersson.  Prospective pharmacologic therapies for the overactive bladder , 2009, Therapeutic advances in urology.

[12]  K. McVary,et al.  Sildenafil citrate improves erectile function and lower urinary tract symptoms independent of baseline body mass index or LUTS severity. , 2008, Urology.

[13]  F. Giuliano.  Phosphodiesterase type 5 inhibitors improve male lower urinary tract symptoms. , 2008, European urology.

[14]  F. Giuliano.  Lower urinary tract symptoms and sexual dysfunction: a common approach , 2008, BJU international.

[15]  W. D. de Groat,et al.  Bladder Overactivity and Hyperexcitability of Bladder Afferent Neurons after Intrathecal Delivery of Nerve Growth Factor in Rats , 2006, The Journal of Neuroscience.

[16]  G. McMurray,et al.  Animal models in urological disease and sexual dysfunction , 2006, British journal of pharmacology.

[17]  P. Abrams,et al.  Impact of overactive bladder symptoms on employment, social interactions and emotional well‐being in six European countries , 2006, BJU international.

[18]  G. Holstege.  Micturition and the soul , 2005, The Journal of comparative neurology.

[19]  C. Fowler,et al.  Functional imaging and the central control of the bladder , 2005, The Journal of comparative neurology.

[20]  M. Miyazato,et al.  Central nervous control of micturition and urine storage. , 2005, Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi.

[21]  F. Cruz.  Mechanisms involved in new therapies for overactive bladder. , 2004, Urology.

[22]  B. Blok,et al.  Brain Control of the Lower Urinary Tract , 2002, Scandinavian journal of urology and nephrology. Supplementum.

[23]  K. Andersson.  Overactive Bladder--Pharmacological Aspects , 2002, Scandinavian journal of urology and nephrology. Supplementum.

[24]  M. Namiki,et al.  Expression of neural plasticity related gene in the pontine tegmental area of rats with overactive bladder after cerebral infarction. , 2001, The Journal of urology.

[25]  M. S. Jeong,et al.  The role of spinal and peripheral α1‐ and α2‐adrenoceptors on bladder activity induced by bladder distension in anaesthetized rat , 2000 .

[26]  S. Mense,et al.  Increased spinal expression of c-Fos following stimulation of the lower urinary tract in chronic spinal cord-injured rats , 1999, Histochemistry and Cell Biology.

[27]  W. Steers,et al.  Spinal and peripheral mechanisms contributing to hyperactive voiding in spontaneously hypertensive rats. , 1998, The American journal of physiology.

[28]  L. Marson,et al.  Identification of central nervous system neurons that innervate the bladder body, bladder base, or external urethral sphincter of female rats: A transneuronal tracing study using pseudorabies virus , 1997, The Journal of comparative neurology.

[29]  R. Faull,et al.  The use of c-fos as a metabolic marker in neuronal pathway tracing , 1989, Journal of Neuroscience Methods.

[30]  M. Drake,et al.  Animal models in overactive bladder research. , 2011, Handbook of experimental pharmacology.